Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-008659
Filing Date
2025-11-10
Accepted
2025-11-10 17:59:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5588
  Complete submission text file 0001950047-25-008659.txt   7074
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Subject) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-50768 | Film No.: 251467663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 144